Holen Sie sich die Stockscreener-App
8.93
1.36%
0.12
Handel nachbörslich:
8.93
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
Form DEFA14A AVADEL PHARMACEUTICALS - StreetInsider
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Wall Street Analysts See an 81.61% Upside in Avadel (AVDL): Can the Stock Really Move This High? - Yahoo Finance
Surging Earnings Estimates Signal Upside for Avadel (AVDL) Stock - Yahoo Finance
AVDL Stock Update: Avadel Pharmaceuticals plc’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Purchased by California State Teachers Retirement System - Defense World
Is Avadel Pharmaceuticals (NASDAQ:AVDL) Using Debt In A Risky Way? - simplywall.st
Following a 34% decline over last year, recent gains may please Avadel Pharmaceuticals plc (NASDAQ:AVDL) institutional owners - Yahoo Finance
Avadel Pharmaceuticals PLC (AVDL) Stock Price Up 3.29% on Jun 9 - GuruFocus
Lifesci Capital Has Optimistic Outlook of AVDL Q2 Earnings - Defense World
FDA Grants Orphan Drug Designation to IH Drug Contender - Sleep Review
Bank of America Corp DE Decreases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel gets FDA's Orphan Drug status for sleep disorder treatment - MSN
FDA grants orphan drug status to Avadel’s IH treatment By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals (AVDL) Secures FDA Orphan Drug Status - GuruFocus
Avadel Pharmaceuticals at Jefferies Conference: Strategic Growth and Challenges By Investing.com - Investing.com UK
Avadel Pharmaceuticals (AVDL) Secures FDA Orphan Drug Status for LUMRYZ | AVDL Stock News - GuruFocus
Avadel Pharmaceuticals Receives FDA Orphan Drug Designation - TipRanks
Avadel Pharmaceuticals Receives Orphan Drug Designation From FDA For Lumryz - MarketScreener
FDA grants orphan drug status to Avadel’s IH treatment - Investing.com Australia
FDA Orphan Drug Designation Gives LUMRYZ 7-Year Market Exclusivity for Sleep Disorder Breakthrough - Stock Titan
AVDL Stock Quote Price and Forecast - CNN
Nuveen Asset Management LLC Purchases 54,773 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025 - MSN
ProShare Advisors LLC Has $322,000 Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025 - The Manila Times
Wall Street Analysts Think Avadel (AVDL) Could Surge 97.68%: Read This Before Placing a Bet - Yahoo Finance
Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - TradingView
BNP Paribas Financial Markets Buys Shares of 23,292 Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $553,000 Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Ameriprise Financial Inc. Lowers Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Recommendation of “Buy” by Brokerages - Defense World
Cetera Investment Advisers Sells 24,747 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel wins appeal to expand LUMRYZ trials beyond narcolepsy By Investing.com - Investing.com Nigeria
Jazz Pharmaceuticals: One Step Forward, One Back (NASDAQ:JAZZ) - Seeking Alpha
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Bought by Northern Trust Corp - Defense World
Chesterfield pharmaceutical company adds C-suite role - The Business Journals
All You Need to Know About Avadel (AVDL) Rating Upgrade to Buy - Yahoo Finance
Avadel Pharmaceuticals: Moving Nicely Through An 'Inflection Year' (NASDAQ:AVDL) - Seeking Alpha
Price T Rowe Associates Inc. MD Acquires 6,445 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals appoints Susan Rodriguez as COO - MSN
AVDL Boosts Leadership with New COO Appointment | AVDL Stock News - GuruFocus
Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer - The Manila Times
Avadel appoints new COO to boost narcolepsy drug growth By Investing.com - Investing.com Canada
Avadel Pharmaceuticals Appoints New Chief Operating Officer - TipRanks
Avadel appoints new COO to boost narcolepsy drug growth - Investing.com
Avadel Pharmaceuticals Expands Leadership Team With Appointment Of Susan Rodriguez As Chief Operating Officer - marketscreener.com
Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference - The Manila Times
Earnings Estimates Moving Higher for Avadel (AVDL): Time to Buy? - Yahoo Finance
Wall Street Analysts Believe Avadel (AVDL) Could Rally 100.21%: Here's is How to Trade - Yahoo Finance
Leerink Partnrs Issues Positive Estimate for AVDL Earnings - Defense World
Equities Analysts Set Expectations for AVDL Q4 Earnings - Defense World
0.54%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):